Ratings by Needham (Stephen Unger)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/6/2021 | Brooks Automation Inc. | BRKS | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2021 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2021 | Brooks Automation Inc. | BRKS | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2020 | OncoCyte Corp | OCX | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2020 | Brooks Automation Inc. | BRKS | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2020 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2020 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2020 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2020 | PerkinElmer | PKI | Upgrade | Buy (Hold) |
113.46 (115.24) |
1.57% | Details | |
| 8/4/2020 | Brooks Automation Inc. | BRKS | Upgrade | Buy (Hold) |
54.57 (113.10) |
107.26% | Details | |
| 7/31/2020 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2020 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | OncoCyte Corp | OCX | New Coverage | Buy (N/A) |
2.73 (5.13) |
87.91% | Details | |
| 4/1/2020 | Bruker | BRKR | Downgrade | Hold (Strong Buy) |
38.55 (36.68) |
-4.85% | Details | |
| 3/6/2020 | CryoPort | CYRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2020 | Agilent | A | Downgrade | Hold (Buy) |
85.07 (115.07) |
35.27% | Details | |
| 2/19/2020 | Bruker | BRKR | Maintain | Strong Buy (N/A) |
|
Details | ||
| 1/31/2020 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2020 | Waters Corp. | WAT | Downgrade | Underperform (Hold) |
231.98 (302.54) |
30.42% | Details | |
| 11/1/2019 | Bruker | BRKR | Maintain | Strong Buy (N/A) |
|
Details | ||
| 10/30/2019 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2019 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2019 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2019 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2019 | Myriad Genetics | MYGN | Maintain | Hold (Hold) |
|
Details | ||
| 7/31/2019 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2019 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2019 | Genomic Health Inc. | GHDX | Downgrade | Hold (Strong Buy) |
68.66 (63.44) |
-7.6% | Details | |
| 7/29/2019 | Myriad Genetics | MYGN | Downgrade | Hold (Strong Buy) |
28.15 (5.15) |
-81.71% | Details | |
| 7/16/2019 | Thermo Fisher Scientific | TMO | Downgrade | Buy (Strong Buy) |
290.94 (501.97) |
72.53% | Details | |
| 7/2/2019 | Veracyte, Inc | VCYT | New Coverage | Buy (N/A) |
28.51 (33.85) |
18.73% | Details | |
| 7/1/2019 | CryoPort | CYRX | New Coverage | Buy (N/A) |
17.95 (8.09) |
-54.93% | Details | |
| 6/19/2019 | Genomic Health Inc. | GHDX | Maintain | Strong Buy (N/A) |
|
Details | ||
| 5/16/2019 | Agilent | A | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2019 | Myriad Genetics | MYGN | Maintain | Strong Buy (Strong Buy) |
|
Details | ||
| 5/9/2019 | Genomic Health Inc. | GHDX | Maintain | Strong Buy (Strong Buy) |
|
Details | ||
| 5/6/2019 | Bruker | BRKR | Maintain | Strong Buy (Strong Buy) |
|
Details | ||
| 4/22/2019 | Thermo Fisher Scientific | TMO | Maintain | Strong Buy (N/A) |
|
Details | ||
| 4/17/2019 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2019 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2019 | Myriad Genetics | MYGN | Maintain | Strong Buy (N/A) |
|
Details | ||
| 2/28/2019 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2019 | Agilent | A | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2019 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2019 | Myriad Genetics | MYGN | Maintain | Strong Buy (N/A) |
|
Details | ||
| 1/3/2019 | Danaher | DHR | New Coverage | Buy (N/A) |
103.12 (195.50) |
89.58% | Details | |
| 1/3/2019 | Neogenomics | NEO | New Coverage | Buy (N/A) |
12.61 (54.34) |
330.93% | Details | |
| 1/3/2019 | Bruker | BRKR | New Coverage | Strong Buy (N/A) |
29.77 (36.68) |
23.21% | Details | |
| 1/3/2019 | Waters Corp. | WAT | New Coverage | Hold (N/A) |
188.65 (231.98) |
22.97% | Details | |
| 1/3/2019 | Myriad Genetics | MYGN | New Coverage | Strong Buy (N/A) |
29.07 (28.15) |
-3.16% | Details | |
| 1/3/2019 | PerkinElmer | PKI | New Coverage | Hold (N/A) |
78.55 (115.24) |
46.71% | Details | |
| 1/3/2019 | Agilent | A | New Coverage | Buy (N/A) |
67.46 (85.07) |
26.1% | Details | |
| 1/3/2019 | Genomic Health Inc. | GHDX | New Coverage | Strong Buy (N/A) |
64.41 (68.66) |
6.6% | Details | |
| 1/3/2019 | Thermo Fisher Scientific | TMO | New Coverage | Strong Buy (N/A) |
223.79 (290.94) |
30.01% | Details |
